Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Michael A. Zimmerman MD, FACS
Professor
Department of Surgery
Division of Transplant Surgery

OFFICE ADDRESS:
Milwaukee, WI 53226

EDUCATION:
06/1988 - 07/1993 Bachelor of Arts, Functional Biology, Magna Cum Laude, California State University, Fresno, CA
08/1993 - 07/1997 Doctor of Medicine, University of California, San Francisco, CA

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/1997 - 12/1997 Internship, Surgery, General Surgery, University of Colorado, 12631 E. 17th Avenue, C-305, Aurora, CO 80045
01/1998 - 06/2004 Resident, Surgery, General Surgery, University of Colorado, 12631 E. 17th Avenue, C-305, Aurora, CO 80045
07/2004 - 07/2006 Multi-Organ Transplant Fellow, Surgery, Liver and Pancreas Transplantation, University of California, Pfleger Liver Institute, 200 Medical Plaza Suite 214, Los Angeles, CA 90095

FACULTY APPOINTMENTS:
06/2004 - 07/2006 Clinical Instructor, Department of Surgery, Division of Liver and Pancreas Transplantation, University of California Pfleger Liver Institute, 200 Medical Plaza Suite 214, Los Angeles, CA 90095
08/2006 - 12/2009 Assistant Professor, Department of Surgery, Division of Transplant Surgery, University of Colorado, 1635 Aurora Ct, C-318, Aurora, CO 80045
01/2010 - 07/2014 Associate Professor, Department of Surgery, Division of Transplant Surgery, University of Colorado, 1635 Aurora Ct, C-318, Aurora, CO 80045
08/2014 - 06/2017 Associate Professor, Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226
07/2017 - Present Professor, Department of Surgery, Transplant Surgery, Medical College of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226

ADMINISTRATIVE APPOINTMENTS:
06/2008 - 07/2014 Surgical Director Pancreas Transplantation Program, Department of Surgery, Division of Transplant Surgery, University of Colorado, 1635 Aurora Ct, C-318, Aurora, CO 80045
08/2014 - Present Medical Director ABO Incompatible Program, Department of Surgery, Division of Transplant Surgery, Solid Organ Transplantation Joint Program Medical College of Wisconsin, Froedtert Health, Children's Hospital of Wisconsin, Blood Center of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226
08/2014 - Present Surgical Director Adult Kidney Transplantation Program, Department of Surgery, Division of Transplant Surgery, Solid Organ Transplantation Joint Program Medical College of Wisconsin, Froedtert Health, Children's Hospital of Wisconsin, Blood Center of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226
08/2014 - Present Surgical Director Pediatric Kidney Transplantation Program, Department of Surgery, Division of Transplant Surgery, Solid Organ Transplantation Joint Program Medical College of Wisconsin, Froedtert Health, Children's Hospital of Wisconsin, Blood Center of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226
08/2014 - Present Surgical Director Adult Pancreas Transplantation Program, Department of Surgery, Division of Transplant Surgery, Solid Organ Transplantation Joint Program Medical College of Wisconsin, Froedtert Health, Children's Hospital of Wisconsin, Blood Center of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226
04/2016 - 08/2016 Medical Director, Blood Center of Wisconsin - Wisconsin Donor Network, 638 North 18th Street, Milwaukee, WI 53233
08/2016 - Present Senior Medical Director, Blood Center of Wisconsin - Wisconsin Donor Network, 638 North 18th Street, Milwaukee, WI 53233

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2009 - 2012 American Society of Transplant Surgeons (ASTS) - Fellowship Training Committee
2009 - 2013 Biliary complications writing group, Ancillary study Principle Investigator- Adult to adult living donor liver transplantation cohort study (A2ALL)
2010 - 2014 Surgical Innovations workgroup - Adult to adult living donor liver transplantation cohort study (A2ALL)
2010 - 2014 Hepatocellular carcinoma workgroup - Adult to adult living donor liver transplantation cohort study (A2ALL)
2010 - 2014 Donor safety workgroup - Adult to adult living donor liver transplantation cohort study (A2ALL)
2010 - 2012 Publications committee - Adult to adult living donor liver transplantation cohort study (A2ALL)
2011 - 2014 Controversies in Transplantation, Planning Committee, March 2014, Breckenridge, Colorado
2012 - 2014 Recipient complications writing group - Adult to adult living donor liver transplant cohort study (A2ALL)
2012 - 2014 World Transplant Congress (WTC) - International Advisory Committee, development of the sunrise symposia and concurrent state-of-the-art symposia. San Francisco, California, July 26-31, 2014
2013 - 2016 American Society of Transplant Surgeons (ASTS) - Living Donation Committee
2014 - 2016 Co-Chair - American Society of Transplant Surgeons (ASTS) - Living Donation Committee
08/2015 - Present Fellowship Program Director, Department of Surgery, Division of Transplant Surgery, American Society of Transplant Surgeons, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226

RESEARCH ADMINISTRATIVE APPOINTMENTS:
08/2014 - Present Director Clinical and Translational Research, Department of Surgery, Division of Transplant Surgery, Solid Organ Transplantation Joint Program Medical College of Wisconsin, Froedtert Health, Children's Hospital of Wisconsin, Blood Center of Wisconsin, 9200 W Wisconsin Ave Suite E5700, Milwaukee, WI 53226

HOSPITAL STAFF PRIVILEGES:
08/2014 - Present Staff Surgeon, Children's Hospital of Wisconsin, Milwaukee, WI 53226
08/2014 - Present Staff Surgeon, Froedtert Memorial Lutheran Hospital, Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
American Board of Surgery
02/07/2006
12/31/2016
American Board of Surgery Recertification
12/08/2015
12/31/2026
 
Licensure
Number Issue DateExpiration
Colorado Medical License
44600
04/2006
07/2014
Wisconsin Medical License
62843-20
08/25/2014
10/31/2019
 

AWARDS AND HONORS:
1993 - 1994 UCSF School of Medicine Research Fellowship, University of California, San Francisco
1995 Bristol-Meyers Squibb Fellowship in Academic Medicine, University of California, San Francisco
1997 UCSF Dean's Award in Student Research, University of California, San Francisco
2004 Ben Eisman Surgical Resident Research Award, Vascular Research Laboratory, University of Colorado, Department of Surgery
2010 - 2014 Mentored Clinical Scientist Development (K08) - 1KO8HL103900, National Institute of Health

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2005 - Present International Liver Transplant Society
2005 - Present American Society of Transplant Surgeons
2005 - Present Association for Academic Surgery
2006 - Present American College of Surgeons (Fellow)
2009 - Present American Society of Transplantation
2010 - Present American Association for the Study of Liver Diseases
2011 - 2014 Denver Academy of Surgery

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2011 - 2015 PloSONE
Editorial Board
2008 - 2010 World Journal of Gastroenterology
2011 - Present Journal of Surgical Research
2014 - Present Transplantation Proceedings
Journal Review
2007 - 2013 Liver Transplantation
2007 - Present Journal of Surgical Research
2007 - 2009 Transplant International
2008 Clinical Medicine: Oncology
2009 Transplantation Proceedings
2009 Current Drug Targets
2009 - Present American Journal of Transplantation
2011 - 2013 Archives of Surgery
2012 PloSONE
2013 JAMA Surgery
2013 Therapeutic Advances Gastroenterology
2013 Liver International
2013 Clinical Transplantation
2016 - Present Transplantation
2016 - Present Journal of Gastroenterology and Hepatology

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Advancing renal TRANSplant eF-ficacy and safety Outcomes with an everRolimus-based regiMen (TRANSFORM). A 24-month, multicenter, randomized, open-label and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs. mycophenolate with standard calcineurin inhibitor in de novo renal transplantation.
Source:
Novartis
Role:
Co-Principal Investigator
PI:
Johnny Hong, MD
Dates:
10/2013 - 12/2018
Direct Funds:
$144,295
 
Non-Peer Review
Title:
Mitochondrial Redox Levels in Mouse Liver Ischemia Model. This pilot study aims to investigate the correlation between the mitochondrial redox levels in liver tissue and severity of liver ischemia and reperfusion injury using a mouse liver ischemia model.
Role:
Co-Principal Investigator
PI:
Johnny Hong, MD
Dates:
02/2015 - 02/2018
 
Title:
Rat Ischemia Reperfusion Model. This study aims to compare the outcomes between the two methods of liver reperfusion in a rat liver warm ischemic model: regulated hepatic reperfusion with leukocyte filtered whole blood versus using non-filtered diluted blood.
Role:
Co-Principal Investigator
PI:
Johnny Hong, MD
Dates:
05/2015 - 05/2018
 
Title:
KDPI and Predictor of Kidney Graft Survival. Is it enough? This is a retrospective study investigating the correlation between the Kidney Donor Predictive Index (KDPI) of the kidneys transplanted to graft survival outcomes.
Role:
Co-Principal Investigator
Dates:
06/2015 - 12/2015
 
Pending
Non-Peer Review
Title:
A Randomized Controlled Clinical Trial of Thymoglobulin® and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection After Liver Transplantation: A Multi-Center Study
Source:
Sanofi
Role:
Principal Investigator
Dates:
05/2016 - 05/2018
 
Prior
Peer Review
Title:
Early autoimmune-mediated vascular injury in the setting of Type I diabetes.
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2006 - 07/01/2008
Direct Funds:
$25,000
 
Title:
Early autoimmune-mediated vascular injury in the setting of Type I diabetes.
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2007 - 07/01/2009
Direct Funds:
$20,000
 
Title:
Evaluation of survival and morbidity in liver transplantation using mycophenolic acid and sirolimus versus mycophenolic acid and calcineurin inhibitors for primary immunosuppression.
Source:
Novartis
Role:
Principal Investigator
Dates:
07/01/2008 - 07/01/2010
Direct Funds:
$140,000
 
Title:
Early autoimmune-mediated vascular injury in the setting of Type I diabetes
Source:
NIH/NHLBI
Role:
Principal Investigator
Dates:
07/01/2010 - 07/01/2014
Direct Funds:
$661,500
 
Title:
Targeting the A2B adenosine receptor during hepatic ischemia and reperfusion injury.
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2010 - 07/01/2012
Direct Funds:
$25,000
 
Title:
Impact of HBIG therapy on the hepatocellular carcinoma recurrence following orthotopic liver transplantation for Hepatitis B.
Source:
Biotest
Role:
Principal Investigator
Dates:
12/01/2010 - 12/01/2012
Direct Funds:
$10,000
 
Title:
Targeting Capase Activity During Renal Ischemia and Reperfusion Injury
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2011 - 07/01/2013
Direct Funds:
$35,000
 
Title:
Extracellular adenosine signaling in liver ischemia and reperfusion injury.
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2012 - 07/01/2014
Direct Funds:
$50,000
 
Title:
Prospective evaluation of the efficacy and safety of Zortress (everolimus)/Myfortic (enteric coated mycophenolate sodium) conversion in high MELD liver transplantation, CRAD001H US63T (RADUS63T).
Source:
Novartis
Role:
Principal Investigator
Dates:
10/01/2012 - 07/01/2014
Direct Funds:
$947,000
 
Title:
Functional role of equilibrative nucleoside transporters in hepatic ischemia and reperfusion injury.
Source:
University of Colorado
Role:
Principal Investigator
Dates:
07/01/2013 - 07/01/2014
Direct Funds:
$50,000
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Treatment Strategies for Hepatocellular Carcinoma: How Far Can We Go?, University of Colorado Grand Rounds, Denver, CO, 04/2010
The History of Liver Transplantation at the University of Colorado: Early Days to Live Donation, Saint Joseph’s General Surgery Residency Program, Denver, CO, 06/2010
Outcomes Following Living Donor Liver Transplant. Update in Liver Disease Management for 2012: Including Highlights from AASLD 2011, Denver, CO, 01/2012
The Evolution of Liver Transplant at the University of Colorado, University of Colorado Grand Rounds, Denver, CO, 04/2012
Advances in Kidney and Pancreas Transplantation, Colorado Center for Transplantation Care, Research and Education. University of Colorado, Denver, CO, 02/20/2013
Twenty-five Years of Liver Transplantation at the University of Colorado, Advanced Concepts in Organ Transplant Nursing Symposium. University of Colorado School of Medicine, Denver, CO, 09/05/2013
Equilibrative Nucleoside Transporters (ENTs) in Liver Ischemia/Reperfusion Injury and Regeneration, Organ Protection Program, University of Colorado, Research in Progress., Denver, CO, 11/15/2013
Current State of Living Donor Liver Transplantation, Medical College of Wisconsin, Transplant Grand Rounds, Milwaukee, WI, 03/03/2014
Surgical Treatment of Hepatocellular Carcinoma: How Far Can We Go?, University of Colorado, Denver, Department of Surgery Grand Rounds., Denver, CO, 05/12/2014
The role adenosine signaling in liver ischemia and reperfusion injury, Medical College of Wisconsin 2nd Annual Solid Organ Transplantation Research Symposium, Milwaukee, WI, 10/22/2014
Living Donor Liver Transplantation and Future Initiatives, International Transplant Nurses Society, Milwaukee, WI, 10/25/2014
The Evolution of Living Donor Liver Transplant, Medical College of Wisconsin Grand Rounds, Milwaukee, WI, 08/26/2015
 
Regional
Program Faculty Controversies in Transplantation, Breckenridge, CO, 2007 - 2013
Aggregate Morbidity and Resolution of Biliary Complications after Living Donor and Deceased Donor Liver Transplantation: A Report from the Adult-to-Adult Living Donor Liver Transplantation Cohort study (A2ALL), American Transplant Congress 2012, Boston, MA, 06/02/2012 - 06/06/2012
 
National
Program faculty, American Society of Transplant Surgeons 5th Annual Surgical Fellows Symposium, Scottsdale, AZ, 11/12/2009 - 11/14/2009
Program faculty, American Society of Transplant Surgeons 4th Annual Surgical Fellows Symposium, Scottsdale, AZ, 11/11/2010 - 11/13/2010
Program faculty, American Society of Transplant Surgeons 3rd Annual Surgical Fellows Symposium, Scottsdale, AZ, 09/21/2011 - 09/24/2011
Essentials of DBD and DCD Multi-Organ Procurement: Don’t Leave Home Without It, American Society of Transplant Surgeons, Fellows Symposium, Scottsdale, AZ, 2011
Program faculty Update in Liver Disease Management for 2012: Including Highlights from AASLD 2011, 2011
Biliary Complications Following Living Donor Liver Transplant, Controversies in Transplantation 2012, Breckenridge, CO, 03/01/2012 - 03/03/2012
Moderator, Living Donor Liver Transplantation, American Transplant Congress, Seattle, WA, 05/18/2013 - 05/22/2013
Discussant. Biomarkers and Genetic Determinants of Disease. Abstract: The role of high mobility group protein B1 (HMGB1) in hepatic ischemia and reperfusion injury, American College of Surgeons, Surgical Forum, Washington, DC, 10/08/2013
Induction of CD39 and CD73 During Human Liver Transplantation Correlates to Ischemic Injury in Knockout Mice., American Society of Transplant Surgeons, State of the Art Winter Symposium, Meeting the Challenges of Innovation, Miami Beach, FL, 01/25/2014
 

EXTRAMURAL TEACHING:
Continuing Medical Education
2006 - 2014 Attending duties: Supervision and teaching of our fellow, residents, and medical students, as well as elective and emergent liver, kidney, and pancreas transplants
2008 - 2014 Mentored Scholarly Activity Program, University of Colorado, School of Medicine: Mentor to 4 medical students from 2008 to 2014
2008 - 2014 Surgical Director, University of Colorado combined kidney/pancreas transplant program (2008-2014). Re-established the pancreas transplant program in 2008. Developed comprehensive post-pancreas transplant antibiotic and anticoagulation treatment regimens. Implemented routine use of intra-operative arterial Doppler for early detection of graft thrombosis
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Maria Kaplan, BS, Professional Research Assistant. Role of adenosine 2B receptor signaling in liver ischemia and reperfusion injury. Mucosal Inflammation Program, University of Colorado, Denver, CO, 2009 - 2014 Research Mentor
Chelsea Ruller, BS, Professional Research Assistant. Functional role of equilibrative nucleoside transporters in liver regeneration, 2013 - 2014 Research Mentor
 
Medical Students
W.R. Halgrimson, MD, University of Colorado School of Medicine, 2010 - 2012 Academic and Clinical Mentor
 
Postdoctoral Students
Eunyoung Tak, PhD, Post-Doctoral Fellow, Adora 2b signaling in liver ischemia/reperfusion and regeneration, 2013 - 2014 Clinical and Research Mentor
 
Clinical/Research Fellows
Paul J. Campsen, MD, University of Utah Transplant Center, Department of Surgery, Salt Lake City, Utah, 2008 - 2010 Clinical and Research Mentor
Trevor Nydam, MD, University of Colorado, Department of Surgery, Division of Transplant Surgery, Denver, CO, 2010 - 2012 Clinical and Research Mentor
Jonathan Roach, MD, University of Colorado, The Children’s Hospital, Department of Pediatric Surgery, Denver, CO, 2011 - 2013 Clinical and Research Mentor
Esam Aboutaleb, MD, 2012 - 2014 Clinical and Research Mentor
Thomas Chirachella, MD, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA, 2013 - 2015 Clinical and Research Mentor
Motaz Selim, MD, Medical College of Wisconsin, Milwaukee, WI, 07/01/2015 - 06/30/2017 Academic and Clinical Mentor
 
Residents
Mara A. Kelly, MD, Mentored Scholarly Activity Program, University of Colorado School of Medicine, Department of Surgery, General Surgery Residency Program, 2008 - 2014 Research Mentor
Afshin Skibba, MD, University of Colorado School of Medicine, University of Southern California, General Surgery Residency Program, 2008 - 2010 Research Mentor
 

ABSTRACT REVIEW:
05/30/2010 - 06/03/2010 American Transplant Congress (May 30-June 3), Boston, MA
05/01/2011 - 05/05/2011 American Transplant Congress (May 1-5), San Diego, CA
04/30/2012 - 05/04/2012 American Transplant Congress (April 30-May 4), Philadelphia, PA
05/18/2013 - 05/22/2013 American Transplant Congress (May 18-22), Seattle, WA
07/26/2014 - 07/31/2014 World Transplant Congress (July 26-31), San Francisco, CA
06/11/2016 - 06/15/2016 American Transplant Congress (June 11-15), Boston, MA

GRANT REVIEW:
2014 The University of Utah-Washington University DRC Collaborative Pilot and Feasibility Program
2015 We Care Scientific Review Committee, Department of Surgery, Medical College of Wisconsin


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Melnyk O, Zimmerman MA, Kim KJ, Shuman M. Neutralizing anti-vascular endothelial growth factor inhibits further growth of established prostate cancer and metastasis in a pre-clinical model. J Urol. 1999;161:960-963.
2. Zimmerman MA, Selzman CH, Harken AH. Surgical implications of angiogenesis. Surgery. 1999;125:243-249.
3. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Meng X, Harken AH. VCAM-1 expression is obligatory for endotoxin induced myocardial neutrophil accumulation and contractile dysfunction. Surgery. 2001;130:319-325.
4. Raeburn CD, Cleveland JC, Zimmerman MA, Harken AH. Organ preconditioning. Arch Surg. 2001;136:1263-1266.
5. Selzman CH, Miller SA, Zimmerman MA, Harken AH. The case for β-adrenergic blockade as prophylaxis against perioperative cardiovascular morbidity and mortality. Arch Surg. 2001;136:286-290.
6. Zimmerman MA, Selzman CH, Raeburn CD, Calkins CM, Barsness K, Harken AH. Clinical applications of cardiovascular angiogenesis. J Cardiac Surg. 2001;16:490-497.
7. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Pomerantz BJ, McIntyre RC jr., Harken AH, Meng X. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am J Physiol Heart and Circ Physiol. 2002;283:H650-657.
8. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken AH. Lack of TNFα attenuates intimal hyperplasia following mouse carotid injury. Am J Physiol Regul Integr Comp Physiol. 2002;283:R505-512.
9. Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Harken AH, Meng X. ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. Am J Physiol Regul Integr Comp Physiol. 2002:283:R477-486.
10. Zimmerman MA, Selzman CH, Raeburn CD, Reznikov LL, Barsness K, Mc Intyre RC, Hamiel, Harken AH. Interleukin-11 attenuates human vascular smooth muscle proliferation. Am J Physiol Heart and Circ Physiol. 2002;283:H175-180.
11. Albright TN, Zimmerman MA, Selzman CH. Vasopressin in the cardiac surgery intensive care unit. Am J Crit Care. 2002:11:331-332.
12. Zimmerman MA, Albright TN, Raeburn CD, Selzman, CH. Vasopressin in the cardiovascular patient: therapeutic implications. Expert Opin Pharmacother. 2002;3:505-512.
13. Raeburn CD, Calkins CM, Zimmerman MA, Arya J, Barsness KA, Harken AH. Toll-like receptors and surgical disease. Surgery. 2002;131:477-483.
14. Raeburn CD, Zimmerman MA, Arya J, Banerjee A, Harken AH. Stem cells and myocardial repair. JACS;195:686-693.
15. Raeburn CD, Zimmerman MA, Arya J, Barsness K, Harken AH. Ischemic preconditioning – Fact or Fantasy. J Cardiac Surg. 2002:17;536-542.
16. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee A. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart and Circ Physiol. 2002;238:H1455-1461.
17. Zimmerman MA, Cothren C, Sorensen AC, Raeburn CD, Selzman CH, Harken AH. Diagnostic implications of c-reactive protein. Arch Surg. 2003;138:220-224.
18. Zimmerman MA, Reznikov LL, Sorensen A, Selzman CH. Relative contribution of the TNFα receptors to intimal hyperplasia. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1213-1218.
19. Selzman CH, Zimmerman MA, Campbell DN. ALCAPA in an adult with preserved left ventricular function. J Cardiac Surg. 2003;18:25-28.
20. Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello CA. Atherogenic effects of Chlamydia pneumoniae: Refuting the innocent bystander hypothesis. J Thorac Cardiovasc Surg. 2003;126:688-693.
21. Zimmerman MA, Trotter JF. Living donor liver transplantation in patients with hepatitis C. Liver Transpl. 2003;9:S52-57.
22. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman CH. Interleukin-10 attenuates the response to vascular injury. J Surg Res.2004;121:206-213.
23. Raeburn CD, Zimmerman MA, Banerjee A, Cleveland JC, Harken AH. Surgical applications of organ preconditioning. Minerva Chir. 2004; 59:209-218.
24. Barbick B, Cothren CC, Zimmerman MA, Moore EE. Posttraumatic pneumatocele. J Am Coll Surg. 2005;2:306-307.
25. Cameron AM, Truty J, Truell J, Lassman C, Zimmerman MA, Kelly BS, Farmer DG, Hiatt JR, Ghobrial RM, Busuttil RW. Fulminant hepatic failure from primary hepatic lymphoma: Successful treatment with orthotopic liver transplantation and chemotherapy. Transplantation. 2005:80:993-996.
26. Zimmerman MA, Cameron AM, Ghobrial RM. Budd-Chiari Syndrome. Clinics in Liver Disease. 2006;10:259-273.
27. Zimmerman MA, Ghobrial RM. When shouldn’t we retransplant. Liver Transpl. 2005;11:S14-20.
28. Zimmerman MA, Busuttil RW. What is the long-term efficacy of thermal ablation for patients with recurrent hepatocellular carcinoma after hepatectomy? Nature Clinical Practice Gastroenterol Hepatol. 2006;3:251-252.
29. Yersiz H, Cameron AM, Carmody I, Zimmerman MA, Kelly BS, Ghobrial RM, Farmer DG, Busuttil RW. Split liver transplantation. Transpl Proc. 2006:38;602-603.
30. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, Zimmerman M, Hong J, Collins TE, Gornbein J, Amersi F, Weaver M, Cao C, Chen T, Hiatt JR, Busuttil RW. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006:243;748-753.
31. Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han SH, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg. 2006:244;563-571.
32. Campsen J, Zimmerman MA, Trotter JF, Mandell S, Wachs M, Bak T, Kam I. Sirolimus and liver transplantation: Clinical implications for hepatocellular carcinoma. Expert Opin Pharmacother 2007:8;1275-1281.
33. Foster R, Zimmerman M, Trotter JF. Expanding donor options: Marginal, living, and split donors. Clinics in Liver Disease 2007:11;417-429.
34. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F, Steinberg T, Bennett W, Kam I. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: A single-center experience. Transpl Int 2007:29;747-753.
35. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Kam I. Clinically recurrent primary sclerosing cholangitis following liver transplant: A time course. Liver Transpl 2008:14;181-185.
36. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Busuttil RW. Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Tranpl Proc 2007:39;3276-3280.
37. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil RW. Recurrence of hepatocellular carcinoma following liver transplantation: A review of pre- and postoperative prognostic indicators. Arch Surg 2008:143;182-188.
38. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Skibba A, Kam I. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Liver Transpl 2008:14;633-638.
39. Campsen J, Hendrickson RJ, Zimmerman MA, Wachs M, Bak T, Russ P, Bennet W, Trotter J, Kam I. Adult right lobe live donor liver transplantation without reconstruction of the middle hepatic vein: A single center study of 109 cases. Transplantation 2008:85;775-777.
40. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Wright F, Kam I. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl 2008:14;1281-1286.
41. Mandell SM, Lindenfeld J, Tsou M, Zimmerman MA. Cardiac evaluation of liver transplant candidates. W J Gasteroenterol 2008:14;3445-3451.
42. Campsen J, Zimmerman MA, Schoen J, Wachs M, Bak T, Mandell MS, Kam I. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obesity Surgery 2008:18;1625-1627.
43. Mandell MS, Zimmerman MA, Campsen J, Kam I. Bariatric surgery in liver transplant patients: weighing the evidence. Obesity Surgery 2008:18;1515-1516.
44. Zimmerman MA, Flores SC. Autoimmune-mediated oxidative stress and endothelial dysfunction: Implications of accelerated vascular injury in type I diabetes. J Surg Res 2009:155;173-178.
45. Bennet W, Zimmerman MA, Campsen J, Mandell MS, Bak T, Wachs M, Kam I. Choledochoduodenostomy is a safe alternative to roux-en-y choledochojejunostomy for biliary reconstruction in liver transplantation. World J Surg 2009:33;1022-1025.
46. Mandell MS, Campsen J, Zimmerman M, Biancofiore G, Tsou M. The clinical value of early extubation. Curr Opion Organ Translant 2009:14;297-302.
47. Campsen J, Zimmerman MA, Mandell MS, Wachs M, Bak T, Forman L, Steinberg T, Kam I. Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation 2009:87;1842-1845.
48. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I. Liver transplantation for primary biliary cirrhosis: Results of aggressive corticosteroid withdrawal. Transpl Proceedings 2008:41;1707-1712.
49. Halgrimson WR, Campsen J, Mandell MS, Kelly MA, Kam I, Zimmerman MA. Donor complications following laparoscopic compared to hand-assisted living donor nephrectomy: An analysis of the literature. J Transpl 2010:825689.
50. Zimmerman MA, Kelly MA, Campsen J, Mandell MS, Wachs M, Bak T, Skibba A, Lancaster B, Kam I. The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation. Clin Transplant 2010:24;E103-108.
51. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, Randall JA, McMahan R, Zimmerman MA, Rangachari M, Dobrinski E, Busson P, Polyak SJ, Hirashima M, Rosen HR. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PloS ONE 2010:5;e9504.
52. Jani A, Zimmerman MA, Martin J, Lu L, Turkmen K, Ravichandran K, Pacic A, Ljubanovic D, Edelstein C. Pulsatile perfusion reduces apoptosis in a porcine kidney model of donation after cardiac death. Transplantation 2011:27;169-175.
53. Benson AB, Burton JR, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman CC, Rosen HR, Moss M. Differential effect of plasma and red blood cell transfusion on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011:17;149-158.
54. Campsen J, Zimmerman MA, Narkewicz MR, Sokol RJ, Mandell MS, Kam I, Dovel D, Karrer FM. Choledochoduodenostomy in pediatric liver transplantation. Pediatr Transplant. 2011:15;237-239.
55. Zimmerman MA, Haskins K, Bradley B, Gilman J, Gamboni-Robertson F, Flores S. Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res. 2011:168;e195-202.
56. Campsen J, Zimmerman MA, Mandell S, Kaplan M, Kam I. A decade of experience using mTor inhibitors in liver transplantation. J Transpl 2011:913094.
57. Cheng SS, Berman GW, Meritt GR, Hendricks A, Fiegel MJ, Teitelbaum I, Wachs M, Zimmerman M, Mandell S. The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anes, 2012:24;324-328.
58. Zimmerman MA, Tak E, Kaplan M, Mandell MS, Eltzschig H, Grenz A. Use of a hanging-weight system for liver ischemia in mice. J Vis Exp, 2012.
59. Campsen J, Ray C, Zimmerman MA, Mandell MS, Kaplan M, Kam I. Diagnosis and correction of hepatic vena caval obstruction following liver transplantation. Indian J Transpl, 2012;6:1-4.
60. Zimmerman M, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the A2ALL consortium. Liver Transpl, 2013;19:259-67.
61. Kelly MA, Kaplan M, Nydam T, Wachs M, Bak T, Kam I, Zimmerman MA. Sirolimus reduces the risk of significant hepatic fibrosis after liver transplantation for hepatitis C virus: A single-center experience. Transpl Proc, 2013;45:3325-8.
62. Tak E, Ridyard D, Badulak A, Giebler A, Shabeka U, Werner T, Clambey E, Moldovan R, Zimmerman MA, Eltzschig HK, Grenz A. Protective role of netrin-1 during diabetic nephropathy. J Mol Med (Berl), 2013:91;1071-1080.
63. Campsen J, Zimmerman MA, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the US using hepatitis B immunoglobulin and nucleoside/nucleotide analogues. Liver Transpl, 2013;19:1020-9.
64. Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS Jr., Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles J, Lukose T, Chang M, Klintmalm G. Multicenter review of liver transplant for hepatitis B–related liver disease: disparities in gender and ethnicity. Clin Transpl, 2013:27:829-837.
65. Zimmerman MA, Kam I, Eltzschig HK, Grenz A. Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury. Am J Transpl, 2013;13:2524-9.
66. Tak E, Ridyard D, Kim JH, Zimmerman MA, Werner T, Wang XX, Shabeka U, Seo SW, Christians U, Klawitter J, Moldovan R, Garcia G, Levi M, Haase V, Ravid K, Eltzschig HK, Grenz A.CD73-Dependent Generation of Adenosine and Endothelial Adora2b Signaling Attenuate Diabetic Nephropathy. J Am Soc Nephrol. 2013:25:547-563.
67. Samstein B, Smith AR, Friese CE, Zimmerman MA, Baker T, Othloff KM, Fisher RA, Merion RM. Complications and their resolution in recipients of deceased and living donor liver transplants: Findings from the A2ALL cohort study. Am J Transplant. 2016:16;594-602.
68. Zimmerman MA, Schiller J, Kim J, Martin A, Selim M, Nydam TL, Cronin D 2nd, Hong JC. Pathologic sequelae of allosensitization in liver transplantation. J Surg Res. 2016 Jan;200(1):195-9. doi: 10.1016/j.jss.2015.06.047. Epub 2015 Jun 26
69. Kim J, Zimmerman MA. Technical aspects for live-donor organ procurement for liver, kidney, pancreas, and intestine. Curr Opin Organ Transplant. 2015 Apr;20(2):133-9.
70. Wedd JP, Nordstrom E, Nydam T, Durham J, Zimmerman M, Johnson T, Purcell T, Biggins SW. Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient. Liver Transpl. 2015:21;1543-1552.
71. Chirichella TJ, Dunham MC, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, Kelley SE, Bak TE, Kam I, Wachs ME. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016:22;3392-3403.
72. Zimmerman MA, Martin A, Hong JC. Basic considerations in organ perfusion physiology. Curr Opin Organ Transplant. 2016:21;288-293.
73. Kim J, Kim T, Hong KS, Moon H, Oh IK, Lee SM, Hohenwalter MD, Zimmerman MA, Cronin DC, Hong JC. Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis. J Invest Surg. 2017 Aug;30(4):265-271.
74. Woehlck HJ, Boettcher BT, Lauer KK, Cronin DC, Hong JC, Zimmerman MA, Kim J, Selim M. Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm. A A Case Rep. 2016 Dec 15;7(12):247-250.
75. Zimmerman MA, Selim M, Kim J, Regner K, Saeian K, Zanowski S, Martin A, Connolly LA, Lauer KK, Woehlck HJ, Hong JC. Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: A single-center experience. Surgery. 2017 05;161(5):1279-1286.
76. Zimmerman MA, Martin A, Yee J, Schiller J, Hong JC. Natural Killer T Cells in Liver Ischemia-Reperfusion Injury. J Clin Med. 2017 Apr 01;6(4). PMCID: PMC5406773
77. Hong JC, Kim J, Browning M, Wagner A, Lerret S, Segura AD, Zimmerman MA. Modified Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Hepatoblastoma in a Small Infant: How Far Can We Push the Envelope? Ann Surg. 2017 08;266(2):e16-e17.
78. Boettcher BT, Woehlck HJ, Reck SE, Hong JC, Zimmerman MA, Kim J, Zundel MT, Freed JK, Pagel PS. Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation. J Cardiothorac Vasc Anesth. 2017 08;31(4):1381-1384.
79. Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg. 2017 09;266(3):525-535.
80. la Cour MF, Mehrvar S, Kim J, Martin A, Zimmerman MA, Hong JC, Ranji M. Optical imaging for the assessment of hepatocyte metabolic state in ischemia and reperfusion injuries. Biomed Opt Express. 2017 Oct 01;8(10):4419-4426. PMCID: PMC5654789
81. Baker TB, Zimmerman MA, Goodrich NP, Samstein B, Pomfret EA, Pomposelli JJ, Gillespie BW, Berg CL, Emond JC, Merion RM. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver Transpl. 2017 12;23(12):1519-1530. PMCID: PMC5818204
82. Kim J, Fons RA, Scott JP, Eriksen CM, Lerret SM, Browning MB, Telega GW, Vitola BE, Hoffman GM, North PE, Vo NN, Zimmerman MA, Hong JC. Transabdominal Intrapericardial Approach in Liver Transplantation for Unresectable Primary Hepatic Functioning Paraganglioma With Invasion Into Hepatic Veins and Suprahepatic Vena Cava: A Surgical and Anesthesia Management Challenge. Transplant Proc. 2018 Nov;50(9):2630-2635.
83. Zimmerman MA, Selim M, Kim J, Kozeniecki M, Hong JC. A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients. Transplant Proc. 2018 Nov;50(9):2619-2621.
84. Kim J, Zimmerman MA, Hong JC. Emerging Innovations in Liver Preservation and Resuscitation. Transplant Proc. 2018 Oct;50(8):2308-2316.
85. Kim J, Zimmerman MA, Lerret SM, Scott JP, Voulgarelis S, Fons RA, Vitola BE, Telega GW, Hoffman GM, Berens RJ, Hong JC. Staged biliary reconstruction after liver transplantation: A novel surgical strategy for high acuity pediatric transplant recipients. Surgery. 2019 02;165(2):323-328.
86. Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study. J Surg Res. 2019 10;242:23-30.
87. DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg. 2020 04;271(4):616-624.
88. Kim J, Martin A, Yee J, Fojut L, Geurts AM, Oshima K, Zimmerman MA, Hong JC. Effects of Hepatic Ischemia-Reperfusion Injuries and NRF2 on Transcriptional Activities of Bile Transporters in Rats. J Surg Res. 2019 03;235:73-82.
89. Zimmerman MA, Selim M, Kim J, Saeian K, Cinquegrani MP, Connolly L, Woehlck HJ, Lauer KK, Hong JC. Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience. Transplant Proc. 2018 Dec;50(10):3544-3548.
90. Benson AB, Burton JR Jr, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman CC, Rosen H, Moss M. Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl. 2011 Feb;17(2):149-58. PMCID: PMC3399914
91. Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. J Surg Res. 2020 11;255:99-105.
92. Pearson T, Zimmerman MA, Kim J, Palines PA, Eriksen CM, Wong M, Selim MA, Markovic D, Hong JC. Staged Biliary Reconstruction After Orthotopic Liver Transplantation: A Practical Surgical Strategy for High-Acuity Adult Recipients. Transplant Direct. 2019 Sep;5(9):e482. PMCID: PMC6739041
 
Books, Chapters, and Reviews
1. Zimmerman MA, Cameron AM, Ghobrial RM. Hepatocellular carcinoma. Controversies in Liver Transplantation, 2008.
2. Campsen J, Zimmerman MA, Bak TE. Liver transplantation. Abernathy’s Surgical Secrets, 6th Edition. 2009;433-435.
3. Campsen J, Zimmerman MA, Bak TE. Kidney and pancreas transplantation. Abernathy’s Surgical Secrets, 6th Edition. 2009;436-438.
4. Zimmerman MA, Campsen J. Budd-Chiari Syndrome. Current Surgical Therapy, 10th Edition. 2010, 329-333.
5. Zimmerman MA, Onaca N, Klintmalm GB. Novel immunosuppression of patients with hepatic malignancies.Transplantation of the Liver, 3rd Edition, (in press).
6. Zimmerman MA, Kam I. Choledochoduodenostomy. Operative Techniques in Transplant Surgery. Michael Mulholland, Daniel Albo, Michael Englesbe, Mary Hawn, Steven Highes, Michael Savel, 1st Edition (in press).
 
Abstracts
1. Miller, SA, Selzman, CH, Pulido, EJ, Zimmerman, MA, Whitehill, TA, Harken, AH. Interleukin-10 (IL-10) attenuates the arterial inflammatory response to injury. Surg Forum, The American College of Surgeons, 2000;191:S72.
2. Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Meng X, Harken AH. Neutralization of IL-18 protects cardiac function during endotoxemia with minimal effect on TNF. J Surg Res. 2001;100:245.
3. Zimmerman MA, Selzman CH, Raeburn CD, Hamiel C, Harken AH. Interleukin-11 attenuates human vascular smooth muscle cell proliferation. J Surg Res. 2001;100:268.
4. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken AH. TNFα is required for neointimal hyperplasia following mouse carotid injury. Surg Forum, The American College of Surgeons, 2001;25.
5. Zimmerman MA, Selzman CH, Miller SA, Raeburn CD, Harken AH. TNFα is required for post-injury neointimal hyperplasia. Circulation. 2001; Supp II-180.
6. Zimmerman MA, Selzman CH, Dinarello C, Raeburn CD, Sorensen BS, Harken AH. Intimal hyperplasia requires adhesion molecule expression but not interleukin-1β. JACS, The American College of Surgeons, 2002; 195:S98.
7. Gordon SA, Uchiyama K, McDiarmid SV, Datta S, Lipshutz G, Cameron AM, Carmdoy IC, Kelly B, Ruiz R, Zimmerman MA, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW. The effect of immunosuppression on ABO incompatible liver transplantation outcomes in the modern era. Liver Transpl. 2005;11:C36.
8. Zimmerman MA, Ghobrial RM, Cameron AM, Tong MJ, Busuttil RW. Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. Am J Transplant, American Transplant Congress, 2006;830:supplement.
9. Zimmerman, MA, Ghobrial RM, Klintmalm GB, Trotter JF, Cameron AM, Gornbein J, Farmer DG, Yersiz H, Busuttil RW. A short-term predictive model of survival following liver re-transplantation. Hepatology, The Liver Meeting 2006.
10. Zimmerman MA, Ghobrial R, Hong J, Trotter J, Cameron AM, Klintmalm G, Busuttil RW. An accurate model to predict survival following retransplantation. The Liver Meeting 2006.
11. Collins T, Ghobrial RM, Hong J, Cameron AM, Gornbein J, Zimmerman MA, Farmer DG, Yersiz H, Gordon RM, Lipshutz G, Busuttil RW. Recurrence risk score predicts cumulative increase in hepatitis C recurrence after liver transplantation. The Liver Meeting 2006.
12. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Kam I. Recurrent primary biliary cirrhosis after liver transplantation at a center practicing corticosteroid minimization. Am J Transpl, American Transplant Congress, 2008:8;286, supplement 2.
13. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Kam I. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Am J Transpl, American Transplant Congress, 2008:8;470, supplement 2.
14. Jani A, Lu L, Zimmerman MA, Ljubanovic D, Edelstein C. Caspase-3 activation in a porcine kidney model of extended criteria donation. Am J Transpl, American Transplant Congress, 2008:8;428, supplement 2.
15. Zimmerman MA, Flores SC. Autoimmune-mediated vascular injury in the setting of type I diabetes. J Surg Res, American Surgical Congress, 2009:151;266.
16. Walcher AM, Denned P, Jani A, Faubell S, Yalavarthy R, Keniston A, Altmann C, Zimmerman MA, Forman L, Roberts M, Devarajan P. Novel biomarkers of acute kidney injury in liver transplant patients. ASN, 2009.
17. Kaplan M, Kelly M, Wachs M, Bak T, Nydam T, Kam I, Zimmerman MA. Sirolimus-based immunosuppression has no influence on recurrent primary sclerosing cholangitis following orthotopic liver transplantation. Hepatology, The Liver Meeting 2010.
18. Zimmerman MA, Kaplan M, Grenz A, Eltzschig H. Adenosine 2B receptor signaling in muring hepatic ischemia-reperfusion injury. J Surg Res, American Surgical Congress, 2011.
19. Kelly, MA, Kaplan M, Smith M, Wachs M, Bak T, Kam, I, Zimmerman MA. Sirolimus reduces the risk of significant hepatic fibrosis and after liver transplantation for hepatitis C virus (HCV): a single center experience. Surgical Forum, The American College of Surgeons, J Am Coll Surg, 2011.
20. A Shaked, S Feng, J Punch, J Reyes, J Levitsky, G Klintmalm, M Zimmerman, M DesMarais, H Kopeskie, A Priore, N Bridges, P Sayre. Initial Outcomes of ITN030ST: Early Post-liver Transplant Immunosuppression Withdrawal. Am J Transpl, American Transplant Congress, 2012:Suppl 3,12;197.
21. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. HBV reinfection after liver transplant is associated with increased recurrent hepatocellular carcinoma and worse survival. Am J Transpl, American Transplant Congress, 2012:Suppl 3, 12,199.
22. Campsen J, Zimmerman MA, Trotter J, Hong JC, Freise C, Brown R, Cameron AM, Ghobrial RM, Kam I, Busuttil RW, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G. Multicenter review of liver transplant for hepatitis B related liver disease: Females and black American do worse. Am J Transpl, American Transplant Congress, 2012:Suppl 3,12;84.
23. Zimmerman MA, Baker T, Freise C, Hong JC, Kumer S, Abt P, Cotterell A, Goodrich NP, Merion RM. Aggregate morbidity and resolution of biliary complications after living donor and deceased donor liver transplantation: A report from the adult-to-adult living donor liver transplantation cohort study (A2ALL). Am J Transpl, American Transplant Congress, 2012:Suppl 3, 12;108.
24. Zimmerman MA, Grenz A, Tak E, Kaplan M, Eltzschig H. Hepatocyte-specific protection by A2B adenosine receptors during ischemia-reperfusion injury of the liver. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2012.
25. Zimmerman MA, Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK. Targeted inhibition of equilibrative nucleoside transporters protects during murine hepatic ischemia/reperfusion injury. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2013.
26. Pomposelli JJ, Humar A, Baker T, Grant D, Goodrich NP, Gillespie B, Merion RM, Kam I, Zimmerman MA, Samstein B, Coterell A, Abt P, Freise C, Emond J and the A2ALL Study Group. “Small for Size Syndrome” (SFSS) after Living Donor Liver Transplantation (LDLT): It’s Not About Size. Report from the Adult to Adult Living Donor Liver Transplantation (A2ALL) Cohort Study. AASLD, 2014.
27. Grenz A, Tak E, Kaplan M, Kam I, Eltzschig HK, Zimmerman MA. Induction of CD39 and CD73 during human liver transplantation correlates to ischemic liver injury in knockout mice. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2014.
28. Lin S, Ruller C, Gralla J, Kam I, Biggins SW, Zimmerman M, Lewis V, Nydam T. Improved renal function post-liver transplant with earlier everolimus (EVL) conversion. Am J Transpl, American Transplant Congress, 2015.
29. Selim M, Johnson C, Saad E, Zimmerman M. Optimal donor/recipient pairing for high KDPI grafts can yield similar survival to medium KDPI grafts. Am J Transpl, American Society of Transplant Surgeons (ASTS) Winter Symposium, 2015.
30. Kim J, North PE, Lerret SM, Bernadette VE, Telega GW, Zimmerman MA, Hong JC. Liver transplantation for non-resectable malignant hepatic paraganglioma: the first case report. Transplantation, International Liver Transplant Society 2016 Congress, Seoul, Korea.
31. Kim J, Martin A, Zimmerman MA, Hong JC. The effect of type and duration of hepatic ischemia on hepatocyte membrane bile transporter expression. Transplantation, International Liver Transplant Society 2016 Congress, Seoul, Korea.
 

jenkins-FCD Prod-486 e3098984f26de787f5ecab75090d0a28e7f4f7c0